Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter October 15, 2017

Anti-angiogenic and anti-lymphangiogenic role of praziquantel and artemether in experimental mansoniasis

Naglaa Fathy Abd El-Aal, Rania Said Hamza and Mona Magdy
From the journal Acta Parasitologica


Angiogenesis is one of the pillars of neoplasia. Lymphangiogenesis in context of granulomas is not yet understood. This study aimed to evaluate the role of praziquantel (PZQ) and artemether (ART) as anti-angiogenic and anti-lymphangiogenic drugs in Schistosoma mansoni induced experimental hepatic model through immunohistochemical and serological studies, this can be used as a potential novel prophylactic approach in hepatic malignancy prevention and possible management. Forty female CD-1 Swiss albino mice were used divided into 4 groups (10 mice each); control healthy, control infected untreated, PZQ-treated and ART-treated. Angiogenic and lymphangiogenic effect of the drugs assessed pathologically through counting of the newly formed capillaries and lymphatics that immunohistochemically expressed by vascular Endothelial Growth Factor (VEGF), CD34 and D2-40 in liver sections using Cell Image Analyzer and serologically by evaluation of serum level of Tumor Necrosis Factor-Alpha (TNF-α). Our results showed significant decrease in serum TNF-α in ART-treated group compared to control infected and PZQ treated groups. ART exhibited significant anti-angiogenic role on granulomas illustrated by remarkable milder intensity and significantly lower expression values of VEGF and CD34 immunostaining compared to PZQ and non-treated groups. Also, ART treated group exhibited negative D2-40 expression in the granulomas in contrast to the other groups, supporting the potent ART‘ anti-lymphangiogenic role that exceeded PZQ. In conclusion, ART showed not only anti-angiogenic effect but also prominent anti-lymphangiogenic effect on hepatic S. mansoni granulomas compared to PZQ. Our study supports the potential use of ART as a potential novel prophylactic approach in hepatic malignancy prevention and possible management.

  1. Conflicts of Interest(s) Authors declare that there is no conflict of interest regarding the publication of this paper.

  2. Financial and funding statement This work funded and financially supported on the expenses of the authors.


Abdel Fattah N.S., Ahmed N.S. 2012. Evidence of intra-hepatic vascular proliferation remodeling early after cure in experimental schistosomiasis mansoni: an immunohistochemical descriptive study. Experimental Parasitology, 130, 58–62. 10.1016/j.exppara.2011.09.014Search in Google Scholar PubMed

Aggarwal B.B. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nature Reviews Immunology, 3, 745–756. 10.1038/nri1184Search in Google Scholar PubMed

Andrade Z.A. 2004. Schistosomal hepatopathy. Memórias do Instituto Oswaldo Cruz 99 (Suppl1), 51–5710.1590/S0074-02762004000900009Search in Google Scholar PubMed

Andrade Z.A. 2009. Schistosomiasis and liver fibrosis. Parasite Immunology 31, 656–663. 10.1111/j.1365-3024.2009.01157.xSearch in Google Scholar PubMed

Andrade Z.A., Santana T.S. 2010. Angiogenesis and schistosomiasis. Memórias do Instituto Oswaldo Cruz Rio de Janeiro, 105, 436–43910.1590/S0074-02762010000400013Search in Google Scholar PubMed

Andrade Z.A., Baptista A.P., Santana T.S. 2006. Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis. Memórias do Instituto Oswaldo Cruz, 101(Suppl 1), 267–27210.1590/S0074-02762006000900041Search in Google Scholar PubMed

Bancroft S., Stevens A.(Eds) 1982. Theory and practice of histological techniques. 2nd ed. Churchill-Livingston, New YorkSearch in Google Scholar

Carmeliet P., Jain R.K. 2000. Angiogenesis in cancer and other diseases. Nature, 407, 249–257. 10.1038/35025220Search in Google Scholar PubMed

Chen H.H., Zhou H.J., Wu G.D., Lou X. E. 2004. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1. Pharmacology, 71, 1–9. 10.1159/000076256Search in Google Scholar PubMed

Chung C., Iwakiri Y. 2013. The lymphatic vascular system in liver diseases: its role in ascites formation. Clinical and molecular hepatology, 19, 99–104. 10.3350/cmh.2013.19.2.99Search in Google Scholar PubMed PubMed Central

DeLeve L.D. 2013. Liver sinusoidal endothelial cells and liver regeneration. Journal of Clinical Investigation, 123, 1861–1866. 10.1172/JCI66025Search in Google Scholar PubMed PubMed Central

Dudek Az., Gupta K., Ramakrishnan S., Mukhopadhyay D. 2010. Tumor angiogenesis. Oncology, 1–2. in Google Scholar PubMed PubMed Central

Fedchenko N., Reifenrath J. 2014. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue – a review. Diagnostic Pathology, 9, 221. 10.1186/s13000-014-0221-9Search in Google Scholar PubMed PubMed Central

Firestone G.L., Sundar S.N. 2009. Anticancer activities of artemisinin and its bioactive derivatives. Expert Reviews in Molecular Medicine Journal, 11, e32.10.1017/S1462399409001239Search in Google Scholar PubMed

Franchitto A., Paolo O., Anastasia R., Guido C., Romina M., Domenico A., Eugenio G. 2013. Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases. HepatoBiliary Surgery and Nutrition 2, in Google Scholar

Gligorijević J., Djordjević B., Petrović A., Radirević A., Stojanović S. 2010. Expression of CD34 in cirrhotic liver—reliance to dedifferentiation. World Journal of Vojnosanit Pregl, 67, 459–46210.2298/VSP1006459GSearch in Google Scholar

Hammam O., Mahmoud O., Zahran M., Sayed A., Salama R., Hosny K., Farghly A.A. 2013. Liver Disease and Hepatocellular Carcinoma. Gastrointestinal Cancer Research, 6,107–114Search in Google Scholar

Harding J., Ritter A., Rayasam A., Fabry Z., Sandor M. 2015. Lymphangiogenesis is induced by Mycobacterial granulomas via vascular endothelial growth factor receptor-3 and supports systemic T-cell responses against Mycobacterial antigen. American Journal of Pathology, 185, 432–445 10.1016/j.ajpath.2014.09.020Search in Google Scholar PubMed PubMed Central

Ho W.E., Peha H.Y., Chan T.K., Wong W.S.F. 2014. Artemisinins: Pharmacological actions beyond anti-malarial. Pharmacology and Therapeutics, 142, 126–139. 10.1016/j.pharmthera.2013.12.001Search in Google Scholar PubMed

Jiraungkoorskula W., Sahaphonga S., Sobhonc P., Riengrojpitaka S., Kangwanrangsan N. 2005. Effects of praziquantel and artesunate on the tegument of adult Schistosoma mekongi harboured in mice. Parasitology International, 54, 177–183. 10.1016/j.parint.2005.04.001Search in Google Scholar PubMed

Kato T., Ito Y., Hosono K., Suzuki T., Tamaki H., Minamino T., et al. 2011. Vascular Endothelial Growth Factor Receptor-1 Signaling Promotes Liver Repair through Restoration of Liver Microvasculature after Acetaminophen Hepatotoxicity. Toxicological Sciences 120, 218–229. 10.1093/toxsci/kfq366Search in Google Scholar PubMed

Keiser J., Utzinger J. 2012. Antimalarials in the treatment of schistosomiasis. Current Pharmaceutical Design 18, 3531–353810.2174/138161212801327293Search in Google Scholar PubMed

Lai W.K., Adams D.H. 2005. Angiogenesis and chronic inflammation; the potential for novel therapeutic approaches in chronic liver disease. Journal of Hepatology, 42, 7–11. in Google Scholar PubMed

Li Q., Weina P., Hickman M. 2013. The Use of Artemisinin Compounds as Angiogenesis Inhibitors to Treat Cancer. Cardiology and Cardiovascular Medicine “Research Directions in Tumor Angiogenesis”, (Ed.) Jianyuan Chai, Chapter7 ISBN 978-953-51-0963-1 10.5772/54109 in Google Scholar

Liang Y.S., Bruce J.I., Boyd D.A. 1987. Laboratory cultivation of schistosome vector snails and maintenance of schistosome life cycles. Proc First Sino-Am Symp, 1, 34–48Search in Google Scholar

Loeffler D.A., Lundy S.K., Singh K.P., Gerard H.C., Hudson A.P., Boros D.L. 2002. Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells. Journal of Infectious Diseases, 185, 1650–1656. 10.1086/340416Search in Google Scholar PubMed

Mantovani A., Schioppa T., Porta C., Allavena P., Sica A. 2006. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Reviews, 25, 315–322. 10.1007/s10555-006-9001-7Search in Google Scholar PubMed

Neuman M.G., Benhamou J.P., Marcellin P, et al. 2007. Cytokine–chemokine and apoptotic signatures in patients with hepatitis C. Translational Research, 149, 126–136. 10.1016/j.trsl.2006.11.002Search in Google Scholar PubMed

Nurden A. 2011. Platelets, inflammation and tissue regeneration. Thrombosis and Haemostasis, 105 (Suppl 1), S13–33. 10.1160/THS10-11-0720Search in Google Scholar PubMed

Ono M. 2008. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli macrophages and cancer cells as targets for therapeutic strategy. Cancer Science, 99, 1501–1506. 10.1111/j.1349-7006.2008.00853.xSearch in Google Scholar PubMed

Pusztaszeri M.P., Seelentag W., Fred T., Bosman F.T. 2006. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. Journal of Histochemistry & Cytochemistry, 54, 385–39510.1369/jhc.4A6514.2005Search in Google Scholar PubMed

Ren S., Abuel-Haija M., Khurana J.S., Zhang X. 2011. D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion. International Journal of Clinical and Experimental Pathology, 4, 175–182Search in Google Scholar

Tawfeek G.M., Alafifi A.M., Azmy M.F. 2003. Immunological indicators of morbidity in human schistosomiasis mansoni: role of vascular endothelial growth factor and anti-soluble egg antigen IgG4 in disease progression. Journal of Egyptian Society of Parasitology, 33, 597–614Search in Google Scholar

Tsuji N., Ishiguro S., Sasaki Y. and Kudo M. 2013. CD34 expression in noncancerous liver tissue predicts multicentric recurrence of hepatocellular carcinoma. Journal of Digestive Diseases, 31, 467–71. 10.1159/000355246Search in Google Scholar PubMed

Van Kruiningen H.J., Hayes A.W., Colombel J.F. 2014. Granulomas obstruct lymphatics in all layers of the intestine in Crohn’s disease. APMIS, 122, 1125–9. 10.1111/apm.12268Search in Google Scholar PubMed

Verheul H.M., Pinedo H.M. 2000. The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitors. Clinical Breast Cancer, 1(Suppl 1), S80–410.3816/CBC.2000.s.015Search in Google Scholar

Wang J., Zhang B., Guo Y., Li G., Xie Q., Zhu B., et al. 2008. Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C. Pharmacology, 82, 148–155. 10.1159/000148261Search in Google Scholar PubMed

World Health Organization 2016. Schistosomiasis. in Google Scholar

Yan Z., Qu K., Zhang J., Huang Q., Qu P., Xu X., et al. 2015. CD147 promotes liver fibrosis progression via VEGF-A/VEGFR2 signalling-mediated cross-talk between hepatocytes and sinusoidal endothelial cells. Clinical Science, 129, 699–710; 10.1042/CS20140823Search in Google Scholar PubMed

Yokomor H., Oda M., Kaneko F., Kawachi S., Tanabe M., Yoshimura K., et al.T. 2010. Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities. BMC Gastroenterology, 10, 131. 10.1186/1471-230X-10-131Search in Google Scholar PubMed PubMed Central

Zhang Z., Yu S., Miao L., Huang X., Zhang X., Zhu Y. 2008. Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial. Chinese Journal of Integrative Medicine, 6, 134–138. 10.3736/jcim20080206Search in Google Scholar PubMed

Received: 2016-12-8
Revised: 2017-6-27
Accepted: 2017-6-28
Published Online: 2017-10-15
Published in Print: 2017-12-20

© 2017 W. Stefański Institute of Parasitology, PAS